BTF acquired by bioMerieux

Friday, 14 September, 2007

Australian company BTF Decisive Microbiology has been acquired by bioMerieux. French clinical diagnostics company bioMérieux is present in more than 150 countries through 35 subsidiaries and has a large network of distributors.

The new acquisition will make BTF's products more accessible to a wider distribution network.

Initially, BTF will operate as a standalone subsidiary, so all existing customers will not see any changes in the short term. BTF's contact details remain unchanged.

Billion-dollar deal for UQ's molecular clamp vaccine tech

Sanofi has entered into an agreement to acquire Vicebio, a biotech company formed in 2018 to...

Director of scandal-ridden Forensic Science Queensland resigns

Dr Linzi Wilson-Wilde resigned from her position one month after being suspended by Queensland...

$492m pathology hub coming to Westmead Health Precinct

The NSW Health Pathology Statewide Hub will be delivered to Westmead Health Precinct, as part of...

Content from other channels on our network

Industrias partners with Hungry Jack's

2025 EnergyLab cohort released

Plan to support Vic's renewable energy

Experts call for change after UN plastics treaty talks fail

Schneider Electric wins Gartner award

Latest Industry Growth Program round awards $28.7 million

ARENA launches battery manufacturing grant program

WA hot briquetted iron plant gets EPA approval

Rockwell appoints Applied Robotics as AMR partner

Carbon280 launches pilot plant for hydrogen storage technology

Could this tracer agent allow surgeons to see and 'hear' prostate cancer?

127 further charges over alleged illegal recording device at Melbourne hospitals

Craigieburn Community Hospital opens in Melbourne's northern suburbs

[New Zealand] Transform from Security Awareness to a Security Culture: A Vital Shift for SMB Healthcare — Webinar

WA establishes $50m older hospitals maintenance fund